This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Xencor, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Gregory M. Hayes: Innovator in Antibody Therapeutics
Introduction
Gregory M. Hayes is a prominent inventor based in Burlingame, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His innovative work has the potential to impact various medical applications.
Latest Patents
One of Gregory M. Hayes' notable patents is titled "Anti-CD39 antibodies and uses thereof." This patent relates to anti-CD39 antibodies, including antibody-drug conjugates that comprise these antibodies, and outlines methods for their use. This invention represents a significant advancement in targeted therapies.
Career Highlights
Gregory M. Hayes is associated with Xencor, Inc., a company known for its innovative approaches in the field of biopharmaceuticals. His work at Xencor has allowed him to explore and develop cutting-edge therapeutic solutions.
Collaborations
Throughout his career, Gregory has collaborated with esteemed colleagues, including Edward Thein H Van Der Horst and Guoqing Chen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Gregory M. Hayes is a key figure in the development of antibody-based therapies, with a focus on anti-CD39 antibodies. His contributions to the field are noteworthy and continue to influence advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile